Skip to main content
Fig. 3 | BMC Rheumatology

Fig. 3

From: Management of Inflammatory Arthritis in pregnancy: a National Cross-Sectional Survey of Canadian rheumatologists

Fig. 3

a Consensus on biologics respondents continue in IA patients planning pregnancy (question 18) and (b) Responses to question on when during pregnancy they are stopped (question 20) (*numbers do not add to 100% as other response options are not on a time-scale [e.g. ‘do not stop’, ‘not sure’]). Abbreviations: ETA – etanercept; ADA – adalimumab; CZP – certolizumab; IFX – infliximab

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us